podcast
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed?
Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape.
Welcome to Talk Radioisotopes: Going Nuclear on Cancer. We’ll take a look at the latest insights, trends and developments working to change patient outcomes and supply the fight against cancer.
Join host Scott Larrivee and experts from across the industry, as they break down the science, shed light on real-world opportunities, and take a peek behind the curtain at the people, companies, and programs driving innovation in nuclear medicine.
Brought to you by the team at Nusano.
episode LIST
Talk Radioisotopes: 2025 Top Podcasts #1
The Talk Radioisopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. At #1 is Atley Solutions' Milton Lönnroth.
Talk Radioisotopes: 2025 Top Podcasts #2
The Talk Radioisopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. Coming in at #2 is Oppenheimer's Jeff Jones.
Talk Radioisotopes: 2025 Top Podcasts #3
The Talk Radioisopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. Coming in at #3 is Clarity Pharmaceuticals' Sheamus Gleason.
Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall
In this episode of Talk Radioisotopes, host Scott Larrivee and guest Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and leadership roles...
Talk Radioisotopes: Sigal Kalmanson Cusnir, CEO and Co-Founder, Starget Pharma
In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and...
Talk Radioisotopes: Milton Lönnroth, Co-Founder and CEO, Atley Solutions
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
Talk Radioisotopes: Matt Furlow, Associate Principal & Head of the ZS Radiopharmaceutical Center of Excellence
On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering...
Talk Radioisotopes: Prof. Suzanne Lapi, University of Alabama at Birmingham
On this episode, hosts Scott Larrivee and Sarah Scouten sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi’s multifaceted role in...
Talk Radioisotopes: Shamar Young, TeleDaaS
On this episode of the Talk Radioisotopes podcast, hosts Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into...
Talk Radioisotopes: Bruno Paquin, AtomVie
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma.Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract...
Talk Radioisotopes: Arjun Murthy, Maven Bio
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, along with Maven Bio's technology, is transforming...
Don’t miss an interview!
Sign up to get news from Nusano and be notified when the Talk Radioisotopes podcast publishes new interviews.